Escolar G, Clemetson K, White J G
Hospital Clinico y Provincial, Barcelona, Spain.
J Lab Clin Med. 1994 Apr;123(4):536-46.
We examined the distribution of glycoprotein Ib (GPIb) and glycoprotein IIb-IIIa (GPIIb-IIIa) receptors on suspension- and surface-activated platelets before and after exposure to thrombin (1 U/ml, 10 minutes). Frozen thin sections prepared from fixed suspension-activated platelets or grids containing fixed surface-activated platelets were stained with specific antibodies to GPIb (antiglycocalicin) and GPIIb-IIIa (AP2 or 7E3), incubated with the corresponding gold-labeled secondary antibody, and examined in the electron microscope. GPIb and GPIIb-IIIa were evenly distributed on membranes of resting and suspension-activated platelets. GPIb and GPIIb-IIIa were present in the open canalicular system (OCS) of resting and, more prominently, in dilated OCS channels of thrombin suspension-activated platelets. On surface-activated platelets more intense labeling for GPIb was observed along pseudopods of dendritic cells whereas GPIIb-IIIa receptors were slightly increased over the peripheral zone. Morphometric study of labeling on fully spread, surface-activated platelets revealed that the density of GPIb increased significantly after thrombin treatment (60.7 +/- 13.1 vs 40.9 +/- 8.3 gold particles/microns 2, p < 0.05). A flow cytometry assay employing the same antiglycocalicin antibody revealed no down-regulation or clearance of GPIb after exposure of platelets to thrombin. GPIIb-IIIa distribution on spread platelets after exposure to thrombin remained basically unchanged (28.4 +/- 10.5 vs 32.6 +/- 10.9 particles/microns2 in nonactivated platelets). These findings indicate that clearance of GPIIb-IIIa and GPIb on suspension-activated platelets does not take place to the extent suggested in previous studies and does not occur spontaneously or after thrombin activation on surface-activated platelets. Although the presence of mobile receptors on platelets is essential for spreading on immobile surfaces and each other, their clearance to the OCS is not a fundamental mechanism regulating adhesion.
我们检测了悬浮激活和表面激活的血小板在暴露于凝血酶(1 U/ml,10分钟)前后糖蛋白Ib(GPIb)和糖蛋白IIb-IIIa(GPIIb-IIIa)受体的分布情况。从固定的悬浮激活血小板制备的冷冻薄片或含有固定表面激活血小板的网格用针对GPIb(抗糖萼蛋白)和GPIIb-IIIa(AP2或7E3)的特异性抗体进行染色,与相应的金标二抗孵育,然后在电子显微镜下检查。GPIb和GPIIb-IIIa在静息和悬浮激活血小板的膜上均匀分布。GPIb和GPIIb-IIIa存在于静息血小板的开放小管系统(OCS)中,在凝血酶悬浮激活血小板扩张的OCS通道中更为明显。在表面激活的血小板上,沿树突状细胞的伪足观察到GPIb的标记更强,而GPIIb-IIIa受体在周边区域略有增加。对完全铺展的表面激活血小板上的标记进行形态计量学研究表明,凝血酶处理后GPIb的密度显著增加(60.7±13.1对40.9±8.3个金颗粒/μm2,p<0.05)。采用相同抗糖萼蛋白抗体的流式细胞术检测显示,血小板暴露于凝血酶后GPIb没有下调或清除。暴露于凝血酶后铺展血小板上的GPIIb-IIIa分布基本保持不变(未激活血小板中为28.4±10.5对32.6±10.9个颗粒/μm2)。这些发现表明,悬浮激活血小板上的GPIIb-IIIa和GPIb的清除程度并不像先前研究所表明的那样,在表面激活血小板上不会自发发生或在凝血酶激活后发生。尽管血小板上存在可移动的受体对于在固定表面上相互铺展至关重要,但它们向OCS的清除并不是调节黏附的基本机制。